Related Experiment Videos
Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
Xiaoxia Sun1, Jian Zhang, Lihua Wang
1Institute of Basic Medical Sciences, Shandong Academy of Medical Science, 89 Jingshi Road, Jinan 250062, China.
Abstract:
More and more studies show that signal transducer and activator of transcription 3 (STAT3) is frequently constitutively activated in a wide number of malignancies and named as an attractive molecular target for tumor treatment. Here, we employed STAT3-decoy ODN, which specifically block over-activated STAT3, to treat human hepatocellular carcinoma (HCC) cells, and evaluated the cellular proliferation ability and investigated the molecular mechanisms in vitro. The results demonstrated that the proliferation of HCC cells was suppressed significantly by STAT3-decoy ODN, being associated with the increased apoptosis and cell arrest at G0/G1 to S phase transition. Further investigates showed the expression of STAT3-regulated genes including bcl-x1, cyclin D1 and c-myc, which involved in cell apoptosis and cell cycle progression, were down-regulated significantly both at transcription and translation levels. These data suggested that STAT3 may be potentially used as a molecular target in HCC therapy.
Insights
Signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotides effectively suppressed hepatocellular carcinoma (HCC) cell proliferation. This targeted therapy induced apoptosis and cell cycle arrest by down-regulating STAT3-regulated genes.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in many cancers.
- Activated STAT3 is a promising molecular target for cancer treatment.
Purpose of the Study:
- To investigate the efficacy of STAT3-decoy oligonucleotides (ODN) in treating human hepatocellular carcinoma (HCC) cells.
- To explore the molecular mechanisms underlying the anti-cancer effects of STAT3-decoy ODN in vitro.
Main Methods:
- Treatment of HCC cells with STAT3-decoy ODN.
- Evaluation of cellular proliferation, apoptosis, and cell cycle progression.
- Analysis of STAT3-regulated gene expression at transcriptional and translational levels.
Main Results:
- STAT3-decoy ODN significantly suppressed HCC cell proliferation.
- Increased apoptosis and cell cycle arrest at the G0/G1 to S phase transition were observed.
- Down-regulation of STAT3-regulated genes (bcl-x1, cyclin D1, c-myc) involved in apoptosis and cell cycle was confirmed.
Conclusions:
- STAT3-decoy ODN demonstrates significant anti-proliferative effects on HCC cells.
- Targeting STAT3 with decoy ODN offers a potential therapeutic strategy for HCC.
- The mechanism involves the inhibition of key genes regulating apoptosis and cell cycle progression.
